Brief: Remus Pharmaceuticals To Make Strategic Investment In Espee Biopharma & Finechem LLC
15/09/2023 08:49
Sept 15 (Reuters) - Remus Pharmaceuticals Ltd REMP.NS :
* TO MAKE A STRATEGIC INVESTMENT IN ESPEE BIOPHARMA &
FINECHEM LLC
* INVESTMENT BY ACQUIRING AND/OR SUBSCRIBING TO MEMBERSHIP
INTEREST OF 51% OR MORE STAKE IN INVESTEE COMPANY
Source text for Eikon: ID:nNSE5CWGZ6
Further company coverage: REMP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Remus Pharmaceuticals
See all newsBrief: Remus Pharmaceuticals Appoints Bhavik Shah As CFO Effective July 09, 2026
Brief: Remus Pharmaceuticals Says Anjali Shah Resigns As CFO
Brief: Remus Pharmaceuticals Re-Appoints Arpit Shah As MD
Brief: Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
Brief: Remus Pharmaceuticals Acquiring Membership Interest Of 56.67% In Espee Global Holdings